Opioid Free Anesthesia and Bariatric Surgery

Northwell Health

Status and phase

Enrolling

Phase 4

Conditions

Postoperative Quality of Recovery

Treatments

Combination Product: Opioid Free Total Intravenous Anesthesia

Combination Product: Total Intravenous anesthesia with opioid

Study type

Interventional

Funder types

Other

Identifiers

NCT04144153

19-0728

Details and patient eligibility

About

The morbidly obese bariatric surgery population is susceptible to opioid-induced complications such as respiratory depression and postoperative nausea and vomiting. This population may in particular benefit from opioid-sparing or opioid-free anesthetic techniques. This study aims to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing bariatric surgery.

Enrollment

58 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

ASA I-III
Non-pregnant
Undergoing laparoscopic bariatric surgery for weight loss.

Exclusion criteria

Unable to obtain informed consent or consent withdrawn.
Patients who are pregnant or nursing.
ASA IV-V
Alcohol or narcotic misuse or dependence in the last 2 years.
Preoperative daily opioid use for one year for pain management.
Egg or soy product allergy
Active liver disease
Patients with left ventricular assist devices
Abnormal renal function
Any contraindication to any opioid or non-opioid pain analgesics
Any physical, mental or medical condition that in the opinion of the investigator, makes study participation inadvisable.